Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NextPlat Corp - Common Stock (NQ:NXPL)

0.7899 -0.0001 (-0.01%)
Streaming Delayed Price Updated: 3:18 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NextPlat Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Web3 Users Surge 40% in Q2, Reach Historic High
Via Investor Brand Network
30 Years Later, Amazon Now Dominates eCommerce
Via Investor Brand Network
Web3 Unveils ‘Trustpilot’ to Close Gap Between Creators, Users
Via Investor Brand Network
TechMediaBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China
Via Investor Brand Network
APhone Unveils DApp Store Providing Web2, Web3 Apps
Via Investor Brand Network
Web3 Marketing Is Leveraging Crypto to Reach More People
Via Investor Brand Network
Millions Join Web3 Games Hosted on Telegram Mini Apps
Via Investor Brand Network
Robots Could Ease Order Fulfilment for eCommerce Companies
Via Investor Brand Network
Commercetools Launches HIPAA-Compliant Innovation to Help Healthcare eCommerce Practitioners
Via Investor Brand Network
Coinbase Report Shows 39% Jump in Web3 Projects by Fortune 100 Companies
Via Investor Brand Network
12 Communication Services Stocks Moving In Monday's After-Market Session
Via Benzinga
Proof of Talk Paris Summit to Discuss Blockchain Policy, Future Prospects
Via Investor Brand Network
How to Minimize E-Commerce Chargeback Losses
Via Investor Brand Network
Topics Fraud
NXPL Stock Earnings: NextPlat Reported Results for Q1 2024
NextPlat just reported results for the first quarter of 2024. 
Via InvestorPlace
Blockchain Technology Revolutionizing AI
Via Investor Brand Network
Topics Artificial Intelligence
Web3 Summit in Dubai Ends Successfully
Via Investor Brand Network
Latest $30M Seed Capital Pushes Web3 Identity Company to Unicorn Status
Via Investor Brand Network
TinyGemsBreaks – NextPlat Corp’s (NASDAQ: NXPL) GTC Begins Sales of SpaceX’s Starlink as Authorized Reseller
Via Investor Brand Network
BioMedNewsBreaks — Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
Via Investor Brand Network
BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Announces Record Consolidated Q1 2024 Revenues, Improved Quarterly Margins
Via Investor Brand Network
Trends, Innovations Shaping Web3 in 2024 and Beyond
Via Investor Brand Network
NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL
From Kahn Swick & Foti, LLC
Via Business Wire
SlowMist Data Shows Web3 Security Breaches Caused Nearly $100M Loss
Via Investor Brand Network
Buyers Demand AI-Supported Tools While Exploring Novel eCommerce Categories
Via Investor Brand Network
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Holdings Corp. (Nasdaq – SNPO), Encore Wire Corporation (Nasdaq – WIRE), Progressive Care Inc. (OTCQB - RXMD), HireRight Holdings Corporation (NYSE – HRT)
From Brodsky & Smith LLC
Via GlobeNewswire
Brussels to Host NFTFest to Foster Web3 Innovation
Via Investor Brand Network
NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL
From Kahn Swick & Foti, LLC
Via Business Wire
NXPL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of NextPlat Corp Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Holdings Corp. (Nasdaq – SNPO), Encore Wire Corporation (Nasdaq – WIRE), Progressive Care Inc. (OTCQB - RXMD), HireRight Holdings Corporation (NYSE – HRT)
From Brodsky & Smith LLC
Via GlobeNewswire
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.